Global Retirement Partners’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,000
Closed -$3.77K 4236
2025
Q3
$3.77K Buy
+1,000
New +$3.86K ﹤0.01% 3079
2024
Q4
$29 Buy
+4
New +$31 ﹤0.01% 3616
2024
Q3
Sell
-2,100
Closed -$14K 3509
2024
Q2
$14K Buy
2,100
+2,000
+2,000% +$14.8K ﹤0.01% 2163
2024
Q1
$1.02K Hold
100
﹤0.01% 2976
2023
Q4
$1.08K Buy
+100
New +$418 ﹤0.01% 2875
2021
Q3
Sell
-4,362
Closed -$43K 1976
2021
Q2
$43K Hold
4,362
﹤0.01% 915
2021
Q1
$62K Buy
4,362
+2,862
+191% +$46.3K 0.01% 703
2020
Q4
$17K Buy
+1,500
New +$17.7K ﹤0.01% 1078

Other funds holding ALT

Global Retirement Partners's ALT Position: Q4 2025 in Review

Global Retirement Partners sold out of Altimmune (ALT) in Q4 2025, closing a stake of 1,000 shares — an estimated $3.77K sold.

Global Retirement Partners first reported a position in ALT in Q4 2020 and held it in 8 quarters. The position peaked at $62K in Q1 2021. 181 funds tracked by Wall St. Rank hold ALT as of Q4 2025.

  • Global Retirement Partners reported no remaining Altimmune position as of Q4 2025 after selling out during the quarter.
  • Global Retirement Partners sold 1,000 Altimmune shares in Q4 2025, an estimated $3.77K.
  • Global Retirement Partners first reported a position in Altimmune in Q4 2020 and held it in 8 quarters.
  • Global Retirement Partners's Altimmune position peaked at $62K in Q1 2021.
  • 181 funds tracked by Wall St. Rank held Altimmune as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.